Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MSOX
Upturn stock ratingUpturn stock rating

AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF (MSOX)

Upturn stock ratingUpturn stock rating
$3.86
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/01/2025: MSOX (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type ETF
Historic Profit -78.42%
Avg. Invested days 12
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
ETF Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/01/2025

Key Highlights

Volume (30-day avg) 244252
Beta -
52 Weeks Range 3.44 - 159.00
Updated Date 04/2/2025
52 Weeks Range 3.44 - 159.00
Updated Date 04/2/2025

ai summary icon Upturn AI SWOT

AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF

stock logo

ETF Overview

overview logo Overview

The AdvisorShares MSOS 2x Daily ETF (MSOX) is a leveraged exchange-traded fund designed to deliver twice the daily performance of the AdvisorShares Pure US Cannabis ETF (MSOS). It focuses on U.S. cannabis companies, seeking to amplify gains (and losses) through its leveraged investment strategy.

reliability logo Reputation and Reliability

AdvisorShares is known for its actively managed ETFs, including several cannabis-focused funds. Their reputation is built on providing niche and specialized investment products.

reliability logo Management Expertise

AdvisorShares has a team with expertise in actively managing ETFs and a focus on emerging sectors like the cannabis industry.

Investment Objective

overview logo Goal

To seek daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the AdvisorShares Pure US Cannabis ETF (MSOS).

Investment Approach and Strategy

Strategy: The ETF employs a leveraged strategy, aiming to magnify the daily returns of its underlying index or assets. This is achieved through financial instruments like swaps or futures.

Composition The ETF's assets primarily consist of financial instruments designed to achieve its 2x leverage target on MSOS. It does not directly hold cannabis stocks, but uses derivatives to mimic the desired performance.

Market Position

Market Share: Limited data on exact market share available, as leveraged ETFs serve a different purpose than unleveraged funds.

Total Net Assets (AUM): 47651879

Competitors

overview logo Key Competitors

  • AdvisorShares Pure US Cannabis ETF (MSOS)
  • CANSLIM ETF (SLAM)

Competitive Landscape

The competitive landscape involves both direct cannabis ETFs and broader growth-oriented ETFs. MSOX differentiates itself through its 2x leveraged strategy, offering higher potential returns (and risks) compared to unleveraged cannabis ETFs like MSOS. This makes it a niche product for risk-tolerant investors.

Financial Performance

Historical Performance: Historical performance is highly dependent on the daily performance of MSOS, amplified by a factor of 2. Past performance is not indicative of future results, especially given the leveraged nature of the fund.

Benchmark Comparison: The ETF's performance should be compared to 2x the daily returns of MSOS. Tracking error may occur due to fees, expenses, and the complexities of maintaining leverage.

Expense Ratio: 1.55

Liquidity

Average Trading Volume

The average trading volume is moderate, indicating acceptable liquidity for most investors, but may fluctuate.

Bid-Ask Spread

The bid-ask spread can vary, particularly during periods of high volatility or low trading volume, potentially impacting trading costs.

Market Dynamics

Market Environment Factors

Economic conditions, regulatory changes in the cannabis industry, and overall market sentiment significantly impact MSOX's performance. Positive developments in cannabis legalization can drive up the value of MSOS and consequently MSOX.

Growth Trajectory

The growth trajectory depends on the U.S. cannabis market's expansion and regulatory environment. As more states legalize cannabis and federal regulations potentially ease, the underlying MSOS ETF and MSOX could experience significant growth. However, this growth is intertwined with regulatory risks.

Moat and Competitive Advantages

Competitive Edge

MSOX's primary competitive advantage is its 2x leveraged exposure to U.S. cannabis companies. This allows investors to potentially amplify their returns if they believe in the sector's short-term growth. This leveraged exposure provides a unique offering not found in traditional unleveraged cannabis ETFs. However, this leverage also amplifies losses, making it a higher-risk investment. The ETF's success hinges on accurately predicting the short-term movements of the U.S. cannabis market.

Risk Analysis

Volatility

MSOX exhibits significantly higher volatility due to its leveraged nature. Daily fluctuations are amplified, leading to greater potential gains and losses compared to unleveraged ETFs.

Market Risk

Market risk is substantial, as MSOX is heavily reliant on the performance of U.S. cannabis companies. Regulatory uncertainty, competition within the industry, and changes in market sentiment all contribute to the ETF's overall risk profile. Compounding risk comes from maintaining 2x leverage, causing the potential for amplified losses and rapid value erosion.

Investor Profile

Ideal Investor Profile

The ideal investor for MSOX is a risk-tolerant, active trader who has a strong understanding of the U.S. cannabis market and is comfortable with leveraged investments. They should have a short-term investment horizon and be prepared for significant price swings.

Market Risk

MSOX is best suited for active traders seeking short-term gains, not for long-term investors or passive index followers. Its leveraged nature makes it unsuitable for risk-averse individuals.

Summary

AdvisorShares MSOS 2x Daily ETF (MSOX) is a leveraged ETF designed to amplify the daily returns of the AdvisorShares Pure US Cannabis ETF (MSOS). It is suited for risk-tolerant, active traders who have a short-term investment horizon and are knowledgeable about the U.S. cannabis market. Its leveraged strategy allows for potentially higher returns, but also increases the risk of significant losses. This ETF is not recommended for long-term investors or those with low risk tolerance. Investors must carefully consider the risks associated with leveraged ETFs before investing.

Similar Companies

MJratingrating

Amplify ETF Trust

$19.64
ETF
0%
PASS

MJratingrating

Amplify ETF Trust

$19.64
ETF
0%
PASS

MSOSratingrating

AdvisorShares Pure US Cannabis ETF

$2.59
ETF
0%
PASS

MSOSratingrating

AdvisorShares Pure US Cannabis ETF

$2.59
ETF
0%
PASS

SLAMratingrating

Slam Corp

$5.52
Small-Cap Stock
2.48%
SELL
SELL since 4 days

SLAMratingrating

Slam Corp

$5.52
Small-Cap Stock
SELL since 4 days
2.48%
SELL

YOLOratingrating

AdvisorShares Pure Cannabis

$2.43
ETF
0%
PASS

YOLOratingrating

AdvisorShares Pure Cannabis

$2.43
ETF
0%
PASS

Sources and Disclaimers

Data Sources:

  • AdvisorShares website
  • SEC filings
  • Various financial data providers

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. Leveraged ETFs are not suitable for all investors and should be used with caution.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About AdvisorShares Trust - AdvisorShares MSOS 2x Daily ETF

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The fund will enter into one or more swap agreements intended to produce economically-leveraged investment results relative to the returns of the US Cannabis ETF. The US Cannabis ETF primarily invests in exchange-listed equity securities, including common and preferred stock, of mid- and small-capitalization companies, and in total return swaps intended to provide exposure to such companies. The fund is non-diversified.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​